top of page
CHEARS
Log In
Home
CHEARS.in
Public Notice
Certifications
Program List
Contact
More
Use tab to navigate through the menu items.
FDA Approves Tecentriq (atezolizumab) for Urothelial Carcinoma
Visual MD
May 22, 2016
bottom of page
